Penn Medicine’s Gary Lichtenstein, MD, a professor of Medicine and Gary Wu, MD, the Ferdinand G. Weisbrod Professor in Gastroenterology were recently recognized by The Crohn’s & Colitis Foundation of America (CCFA) with 2015 Inflammatory Bowel Disease (IBD) Scientific Achievement Awards.

Lichtenstein, who also directs Penn’s Inflammatory Bowel Disease Center, was awarded the Scientific Achievement in IBD Clinical Research Award and Wu won the Scientific Achievement in Basic IBD Research Award.

Lichtenstein has led the Inflammatory Bowel Disease Center for 22 years. His current research has looked into investigational therapies for ulcerative colitis (UC) and Crohn’s disease treatments. He has served as the principal investigator in trials evaluating novel agents in the treatment of UC and Crohn’s disease.

Wu serves as the associate chief for research in Gastroentorology, the co-director of the Penn-CHOP Microbiome Program as well as the associate director of the Center for Molecular Studies in Digestive and Liver Disease at the University of Pennsylvania. He is also an elected member of the American Society for Clinical Investigation and the Association of American Physicians.

The awards were given out at the CCFA’s annual Advances in Inflammatory Bowel Diseases Conference in Orlando, Florida earlier this month. 

Read the original press release here.